EuGMS Task Force on COVID-19

Reach us covid19taskforce(at)eugms.org

Please consult the EuGMS Statement on COVID-19

WHO-Europe dashboard on COVID-19

WHO-Global dashboard on COVID-19

SPRINGER NATURE-Articles on COVID-19 (all articles are free access)
As a leading research publisher and EuGMS EGM Journal partner, Springer Nature is committed to supporting the global response to emerging outbreaks by enabling fast and direct access to the latest available research, evidence, and data.

 

TOPIC 44

Country of origin: - -

Council of Europe - Statement: Lessons to be drawn from the ravages of the COVID-19 pandemic in long-term care facilities 

TOPIC 43

Country of origin: UK

BGS - Age and Ageing: COVID-19 in Older People: A Rapid Clinical Review 

TOPIC 42

Country of origin: Italy

Now available online the recording of the webinar:

SIGOT - Webinar "L'anziano e la pandemia da COVID-19: epidemiologia e clinica nei diversi setting di cura" 

Chairs: Prof Alberto Ferrari, Prof Filippo Fimognari, Prof Alberto Pilotto (see Topic 36)

 TOPIC 41

Country of origin: Poland

Information and Recommendations from the Polish College of Geriatricians [POLISH]

Information and Recommendations from the Polish Society of Gerontology [POLISH]

TOPIC 40

Country of origin: UK

British Geriatrics Society - Age and Ageing journal: Free collection of COVID-19 papers

TOPIC 39

Country of origin: --

EuGMS Special Interest Group on Geriatric Rehabilitation - Response to COVID-19

For more information visit the SIG on Geriatric Rehabilitation page. 

TOPIC 38

Country of origin: Turkey

1) Prevention Advices for Covid-19 Disease for Nursing Homes by the Turkish Academic Geriatrics Society 
2) Protection and Control Recommendations for nursing homes and elderly care centers by the Turkish Ministry of Family Labor and Social Services of the Turkish Republic 
3) Public information brochure for Covid-19 by Turkish Academic Geriatrics Society 
4) Kamu bilgilendirme bro?ürü Uzman gözüyle ya?l?da COVID Akademik Geriatri Derne?i  [TURKISH]
5) Links for simple exercises video that can be performed at home for older adults by the Turkish Academic Geriatrics Society [Türkçe] [TURKISH]

http://www.akademikgeriatri.org/index.php?func=new_content&id=89

https://www.youtube.com/watch?v=2Ka-MMBF7E4

6) Public Information for Coronavirus and older adults by the Elderly Platform 

TOPIC 37

Country of origin: Italy

SIGOT - Forum OLDER ADULTS  AND COVID-19  [ITALIAN]

TOPIC 36

Country of origin: Italy

SIGOT - Webinar "L'anziano e la pandemia da COVID-19: epidemiologia e clinica nei diversi setting di cura" 

Charis: Prof Alberto Ferrari, Prof Filippo Fimognari, Prof Alberto Pilotto

Programme for download [ITALIAN]

TOPIC 35

Country of origin: -

EuGMS Letter to ECDC European Centre for Disease Prevention and Control

TOPIC 34

Country of origin: CHINA

ScienceDirect - Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study

TOPIC 33

Country of origin: -

EuGMS Recommendations for safety and protection of Care Homes against COVID-19 -UPDATE1

TOPIC 32

Country of origin: UK

BGS - Atypical Covid-19 presentations in older people – the need for continued vigilance

TOPIC 31

Country of origin: UK

Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR

TOPIC 30

Country of origin: -

EICA - CoVID-19 Concepts and Their Application to Geriatrics

TOPIC 29

Country of origin: SPAIN

COLLABORATION BETWEEN HOSPITAL GERIATRIC SERVICES - HOSPITAL HALF-STAY - NURSING HOMES AND SOCIAL HEALTH CENTRES [SPANISH TEXT] 

SEGG COVID-19 DECLARATION. Nursing homes and socio-medical centres are the most vulnerable resources to the coronavirus and require our support and urgent actions for protection [SPANISH TEXT]

DOCUMENT SOCIEDAD ESPAÑOLA DE GERIATRÍA Y GERONTOLOGÍA Y SOCIEDAD ESPAÑOLA DE CARDIOLOGÍA: Coronavirus in the elderly patient: a Geriatric emergency [SPANISH TEXT]

TOPIC 28

Country of origin: UK

Centre for Evidence-Based Medicine - Oxford COVID-19 Evidence Service

TOPIC 27

Country of origin: ICELAND

Spread of SARS-CoV-2 in the Icelandic Population

TOPIC 26

Country of origin: SPAIN

Free webinar [IN SPANISH] “COVID-19. NUTRICIÓN DE LAS PERSONAS MAYORES DURANTE EL CONFINAMIENTO” organised by SEGG - Sociedad Española de Geriatría y Gerontología

TOPIC 25

Country of origin: Various Countries

Alzheimer Europe position regarding the allocation of scarce medical resources for intensive care services during the COVID-19 pandemic

TOPIC 24

Country of origin: SPAIN

POSICIONAMIENTO SEMEG RESPECTO DE LAS NECESIDADES Y DERECHOS DEL PACIENTE MAYOR EN LA SITUACIÓN ACTUAL DE PANDEMIA POR COVID-19 [SPANISH TEXT]

TOPIC 23

Country of origin: Various Countries

Respiratory virus shedding in exhaled breath and efficacy of face masks

TOPIC 22

Country of origin: Various Countries

Useful Resources for Geriatric Rehabilitation post COVID-19

TOPIC 21

Country of origin: UK

King’s Critical Care – Evidence Summary - Clinical Management of COVID-19

TOPIC 20

Country of origin: FRANCE

Measures for safety and protection of Care Homes against COVID-19
Recommendations proposed by three Professors of Geriatric Medicine in France
Hubert Blain (Montpellier), Yves Rolland (Toulouse), Athanase Benetos (Nancy)

TOPIC 19

Country of origin: CANADA

ICU Volume 10 - Issue 4 - Ethics of Triage 

TOPIC 18

Country of origin: CHINA

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

TOPIC 17

Country of origin: PORTUGAL

Question: Many things are being written about prescription of Hydroxicloroquine in prevention and treatment of COVID-19 Can we start giving Hydroxicloroquine to our oldest and symptomatic patients. EuGMS has already advice about that?

Answer from EuGMS Task Force on COVID-19: From the medical/scientific point of view we have to be skeptical and seek for more data from controlled clinical studies. On the other side there is an increasing pressure because of the present situation pushing people, physicians and governments to the use of this molecule without solid evidence. We don't use Hydroxycloroquine so far but we hope to have the authorization to test it very soon in a clinical trial we initiate with several other French groups for treating older COVID-19 + patients . May be in the next days we will have some more data allowing us to make a decision.

Friday March 27th

TOPIC 16

Country of origin: UK

National Institute for Health and Care Excellence - NICE - Critical care guidance including frailty

Thursday March 26th

TOPIC 15

Country of origin: BELGIUM

COVID-19, diagnostic, PEC et spécificités SA [FRENCH TEXT]

Thursday March 26th

TOPIC 14

Country of origin: UK

BGS guidelines on management of COVID-19 pandemic in care homes

Wednesday March 25th

TOPIC 13

Country of origin: SPAIN

COVID-19 - Recommendations for nursing homes and social health centres

Tuesday March 24th

TOPIC 12

Country of origin: NORWAY

Norwegian Geriatrics Society - Recommendations and priorities from the Norwegian geriatrics society to the Norwegian health directorate in connection with the COVID-19 pandemia

Tuesday March 24th

TOPIC 11

Country of origin: Various countries

International Evidence Summary on Clinical Management of COVID-19

Monday March 23rd

TOPIC 10

Country of origin: FRANCE - VIETNAM

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial

Monday March 23rd

TOPIC 9

Country of origin: CHINA

BioScience: Letter on the use of Chloroquine phosphate

Monday March 23rd

TOPIC 8

Country of origin: UK

National Institute for Health and Care Excellence - NICE - COVID-19 rapid guideline: critical care

Monday March 23rd

TOPIC 7

Country of origin: UK

Monday March 23rd

TOPIC 6

Country of origin: BELGIUM

Ethical principles concerning proportionality of critical care during the 2020 COVID-19 pandemic in Belgium: advice by the Belgian Society of Intensive care medicine

Read/Download here          

TOPIC 5

Country of origin: CANADA

Discussions about COVID-19 and Frailty from CFN - Canadian Frailty Network – Explanatory Webinars:

TOPIC 4

Country of origin: FRANCE - UK

Question: An increasing number of patients have diarrhoea as a first sign of COVID-19. The opinion of the experts is that if there is no evidence of another cause of diarrhoea, patients with this symptom should be managed as suspected COVID-19 cases. How was the diagnosis in these patients with diarrhoea made: from stool sample PCR or in the usual way with throat swabs etc?

Answer from EuGMS Task Force on COVID-19: in the usual way with throat swabs.

Wednesday, March 18th

TOPIC 3

Country of origin: PORTUGAL

Question: Do you think we can start giving chloroquine to the high-risk elderly population (dwelling elderly population)?
Does EuGMS have any guidelines on this?
I read that the National Health Commission of the People's Republic of China intends to publish guidelines suggesting administering chloroquine to prevent Covid19 infection.

Answer from EuGMS Task Force on COVID-19: There are ongoing clinical studies in order to verify the possible benefits of this treatment. For the moment, the Chinese studies do not offer some relatively solid evidence so my answer to your question is negative. I hope we will soon have some first solid results from the clinical studies in order to propose some efficient treatments.

Monday, March 16th

TOPIC 2

Country of origin: TURKEY

Question: Hi, l am a director of care home in Turkey/Izmir.  We have not patient with corono vit19. But we have been put new rules about hygienic. No acceptance of visitors out of our institution Our nurses reminded the washing hands frequently to our workers and our older people

Answer from EuGMS Task Force on COVID-19: These are safe solutions, but we need to consider also that isolating these patients from their families and friends

TOPIC 1

Country of origin: SERBIA

Question: Creating a EUGMS document was really a good move regarding the recent facts about the COVID 19 virus. In the recent past years, I was interested in, I will say "grey area in geriatrics". The relationship between grandparents and grandchildren. Based also on the messages about the percentages of contamination or infection in the youngest and oldest, I have a question. Everyday life will not erase the contacts between grandparents and grandchildren. The population that is often asymptomatic in contact with high-risk populations. Is there any advice about it?

Answer from EuGMS Task Force on COVID-19: In the present expanding stage of the epidemic we have to avoid the contact between grandchildren (major vector of the disease because asymptomatic) and grandparents. Unfortunately, in families in which both parents work, grandparents play an important role especially when schools are closed as it is the case now in many countries but as far as possible this contact must be avoided.

Friday, March 13th

18.03.2020